| Role of osteopontin in adhesion, migration, cell survival and bone remodeling T Standal, M Borset, A Sundan Exp Oncol 26 (3), 179-84, 2004 | 508 | 2004 |
| Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells T Standal, C Seidel, Ø Hjertner, T Plesner, RD Sanderson, A Waage, ... Blood, The Journal of the American Society of Hematology 100 (8), 3002-3007, 2002 | 333 | 2002 |
| Serum syndecan-1: a new independent prognostic marker in multiple myeloma C Seidel, A Sundan, M Hjorth, I Turesson, IMS Dahl, N Abildgaard, ... Blood, The Journal of the American Society of Hematology 95 (2), 388-392, 2000 | 310 | 2000 |
| Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma C Seidel, M Børset, I Turesson, N Abildgaard, A Sundan, ... Blood, The Journal of the American Society of Hematology 91 (3), 806-812, 1998 | 263 | 1998 |
| Hepatocyte growth factor and its receptor c-met in multiple myeloma M Borset, H Hjorth-Hansen, C Seidel, A Sundan, A Waage | 262 | 1996 |
| Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease C Seidel, Ø Hjertner, N Abildgaard, L Heickendorff, M Hjorth, J Westin, ... Blood, The Journal of the American Society of Hematology 98 (7), 2269-2271, 2001 | 255 | 2001 |
| Toll-like receptors mediate proliferation and survival of multiple myeloma cells J Bohnhorst, T Rasmussen, SH Moen, M Fløttum, L Knudsen, M Børset, ... Leukemia 20 (6), 1138-1144, 2006 | 244 | 2006 |
| Interleukin-21 is a growth and survival factor for human myeloma cells AT Brenne, T Baade Ro, A Waage, A Sundan, M Borset, H Hjorth-Hansen Blood, The Journal of the American Society of Hematology 99 (10), 3756-3762, 2002 | 228 | 2002 |
| HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma T Standal, N Abildgaard, UM Fagerli, B Stordal, Ø Hjertner, M Borset, ... Blood 109 (7), 3024-3030, 2007 | 211 | 2007 |
| Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells: Presented in part at the 41st annual meeting of the American Society of … O Hjertner, H Hjorth-Hansen, M Börset, C Seidel, A Waage, A Sundan Blood, The Journal of the American Society of Hematology 97 (2), 516-522, 2001 | 166 | 2001 |
| Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines M Børset, E Lien, T Espevik, E Helseth, A Waage, A Sundan Journal of Biological Chemistry 271 (40), 24655-24661, 1996 | 166 | 1996 |
| Bone morphogenetic protein-5,-6 and-7 inhibit growth and induce apoptosis in human myeloma cells T Baade Ro, R Utne Holt, AT Brenne, H Hjorth-Hansen, A Waage, ... Oncogene 23 (17), 3024-3032, 2004 | 156 | 2004 |
| Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease Ø Hjertner, ML Torgersen, C Seidel, H Hjorth-Hansen, A Waage, M Børset, ... Blood, The Journal of the American Society of Hematology 94 (11), 3883-3888, 1999 | 147 | 1999 |
| Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins M Børset, Ø Hjertner, S Yaccoby, J Epstein, RD Sanderson Blood, The Journal of the American Society of Hematology 96 (7), 2528-2536, 2000 | 145 | 2000 |
| High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity C Seidel, M Børset, Ø Hjertner, D Cao, N Abildgaard, H Hjorth-Hansen, ... Blood, The Journal of the American Society of Hematology 96 (9), 3139-3146, 2000 | 136 | 2000 |
| Syndecan‐1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival NF Andersen, T Standal, JL Nielsen, L Heickendorff, M Borset, ... British journal of haematology 128 (2), 210-217, 2005 | 131 | 2005 |
| A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells H Hov, RU Holt, TB Rø, UM Fagerli, H Hjorth-Hansen, V Baykov, ... Clinical Cancer Research 10 (19), 6686-6694, 2004 | 122 | 2004 |
| Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro AD Theocharis, C Seidel, M Borset, K Dobra, V Baykov, V Labropoulou, ... Journal of biological chemistry 281 (46), 35116-35128, 2006 | 118 | 2006 |
| Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis AJ Feuerherm, M Børset, C Seidel, A Sundan, L Leistad Scandinavian journal of rheumatology 30 (4), 229-234, 2001 | 112 | 2001 |
| Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells UM Fagerli, RU Holt, T Holien, TK Vaatsveen, F Zhan, KW Egeberg, ... Blood, The Journal of the American Society of Hematology 111 (2), 806-815, 2008 | 111 | 2008 |
